Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
—1,110.341,110.371,117.241,097.84——
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
—620.54620.54622.67611.42——
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
—1,159.201,160.591,177.621,156.21——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
—1,753.441,749.081,762.011,724.74——
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
—648.80649.58655.73643.68——
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
—832.49832.07833.09826.15——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
—219.16219.16219.19214.82——
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
—3,113.363,120.793,143.643,105.16——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
—926.67927.99930.54910.08——
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
—1,489.611,499.051,499.051,474.35——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
—2,423.262,438.162,443.462,399.83——
UQ1:FRA
Uniqure NV
€15.16
+3.41%
(+0.50) 1D
Apr 21, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for UQ1...
Open
€15.16
High
€15.16
Low
€15.16
Mkt. cap
1.09B
Avg. vol.
227.00
Volume
0.00
52-wk high
€60.50
52-wk low
€7.26
No. of employees
221
News stories
From sources across the web
Profile
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
About Uniqure NV
CEOMatt Kapusta
Employees221
Founded1998
Headquarters-
SectorBiotechnology
Websiteuniqure.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.57M
5.26M
3.70M
5.57M
Cost of goods sold
35.12M
33.78M
32.25M
40.18M
Cost of revenue
35.12M
33.78M
32.25M
40.18M
Research and development expenses
-
-
695.00K
-5.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.91M
13.50M
19.44M
21.61M
Operating expense
4.56M
13.09M
20.67M
15.55M
Total operating expenses
39.68M
46.87M
52.91M
55.73M
Operating income
-38.12M
-41.61M
-49.21M
-50.16M
Other non operating income
-
-
-7.22M
18.13M
EBT including unusual items
-43.14M
-37.29M
-71.90M
-41.00M
EBT excluding unusual items
-41.92M
-35.04M
-70.08M
-40.05M
Income tax expense
496.00K
425.00K
8.63M
-3.92M
Effective tax rate
-1.15%
-1.14%
-12.00%
9.55%
Other operating expenses
-6.35M
-412.00K
534.00K
-143.00K
Net income
-43.64M
-37.72M
-80.53M
-37.09M
Net profit margin
-2,784.75%
-716.82%
-2,175.87%
-666.06%
Earnings per share
-
-
-
-
Interest and investment income
4.13M
3.52M
3.50M
5.81M
Interest expense
-15.11M
-15.59M
-16.72M
-14.57M
Net interest expenses
-10.98M
-12.07M
-13.22M
-8.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
-33.59M
-37.98M
-45.58M
-47.19M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer